Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics.
Lu
Kun Ping
KP
Cancer Biology Program, Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. klu@bidmc.harvard.edu
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D014408:Biomarkers, Tumor; D006801:Humans; D025202:Molecular Diagnostic Techniques; D009369:Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D019696:Peptidylprolyl Isomerase / Q000378:metabolism*; D010766:Phosphorylation; D011487:Protein Conformation; D025941:Protein Interaction Mapping; D015398:Signal Transduction / Q000502:physiology
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D019696:Peptidylprolyl Isomerase